An early study conducted in Japanese hereditary breast cancer patients found 2 out of 45 patients contained a RAD51–R150Q variant that is absent among 200 sporadic breast cancer or 100 colon cancer cases, which suggested this site could be a disease-associated mutation (12). This evidence concerns the gene RAD51 and breast cancer.